Matinas biopharma holdings, inc. (MTNB)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Cash flows from operating activities:
Net loss

-17,372

-14,083

-15,486

-7,598

-9,135

-10,221

-3,713

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

205

218

100

52

43

41

-

Change in deferred rent

-

-

157

2

9

0

-

Depreciation

-

-

-

-

-

-

1

Stock based compensation expense

2,985

3,833

3,597

1,518

1,592

1,974

325

Loss on disposal of equipment

-6

-

-

-

-

-

-

Amortization of operating lease right-of-use assets

452

-

-

-

-

-

-

Amortization of finance lease right-of-use assets

122

-

-

-

-

-

-

Amortization of bond discount

0

-

-

-

-

-

-

Deferred tax liability

-

506

-

-

-

-

-

Change in deferred rent

-

57

-

-

-

-

-

Deferred tax liability

-

-

-356

0

0

-

-

Issuance of shares in Matinas Holdings (July 11, 2013)

-

-

-

-

-

-

953

Common stock issued in lieu of bonus

-

-

-

-

-

-

1,252

Changes in operating assets and liabilities:
Grant receivable

-

-

-

0

-45

0

-

Other assets

-

-

-4

480

-100

0

315

Operating lease liabilities

-359

-

-

-

-

-

-

Prepaid expenses and other current assets

1,358

-349

-

-

-

-

-

Prepaid expenses

-

-

-256

-189

111

29

84

Accounts payable

383

-287

107

-22

-73

-125

336

Accrued expenses and other liabilities

842

97

159

-

-

-

-

Accrued expenses - other liabilities

-

-

-

219

-285

400

462

Net cash used in operating activities

-14,092

-10,321

-11,459

-6,118

-7,814

-

-

Cash flows from investing activities:
Purchase of marketable securities

5,605

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-7,961

-2,987

Purchases of leasehold improvements and equipment

405

535

942

0

76

288

94

Acquisition of Aquarius - net of cash acquired

-

-

-

0

-70

0

-

Net cash used in investing activities

-6,011

-535

-942

0

-5

-

-

Cash flows from financing activities:
Net proceeds from public offering of common stock

30,103

-

-

-

-

-

-

Proceeds from common stock, issued for cash

-

-

-

0

10,000

0

15,000

Common stock issuance cost

-

-

-

0

1,485

-

-

Net cash used in investing activities

-

-

-

-

-

-288

-94

Net proceeds from issuance of Series B convertible preferred stock

-

7,056

-

8,000

0

-

-

Net proceeds from ATM sale

-

9,240

-

-

-

-

-

Repayment of loans provided by founders

-

-

-

-

-

-

24

Proceeds from redeemable convertible preferred stock issued for cash

-

-

-

-

-

-

500

Preferred stock issuance costs

-

-

-

1,157

0

-

4

Common stock issuance cost

-

-

-

-

-

-

2,378

Proceeds from exercise of warrants

-

-

14,828

315

0

-

-

Proceeds from exercise of options

30

-

-

-

-

-

-

Net proceeds from ATM sales

-

-

-

0

0

-

-

Warrant tender issuance costs

-

-

-

0

0

-

-

Proceeds from ATM sale, net of commissions of $285,774

-

9,240

-1,122

-

-

-

-

Payments of capital lease liability - principal

81

59

17

15

48

0

-

Payments of note payable

199

370

330

144

10

0

-

Net cash provided by financing activities

29,851

15,867

15,602

6,997

8,456

-

-

Net (decrease)/increase in cash, cash equivalents and restricted cash

9,748

5,009

3,200

-

-

-

-

Proceeds from formation of holding's common stock

-

-

-

-

-

-

375

Proceeds from formation warrants

-

-

-

-

-

-

10

Proceeds from private placement warrants

-

-

-

-

-

-

20

Net cash provided by (used in) financing activities

-

-

-

-

-

0

13,498

Net increase in cash and cash equivalents

-

-

-

878

636

-8,249

-

Net (decrease) increase in cash equivalents

-

-

-

-

-

-

10,416

Supplemental non-cash financing and investing activities:
Unrealized gains on marketable securities

0

-

-

-

-

-

-

Preferred stock conversion into common stock - series A

5,583

133

-

-

-

-

-

Preferred stock conversion into common stock - Series B

210

2,770

-

-

-

-

-

Stock dividends issued and converted to common stock

2,234

14

-

-

-

-

-

Preferred stock conversion into common stock - series A

5,583

133

369

-

-

-

-

Preferred stock conversion into common stock - series B

210

2,770

-

-

-

-

-

Conversion of preferred stock

-

-

-

0

0

-

-

Stock dividends accrual

1,174

587

608

-

-

-

-

Exercise of warrants

10

-

-

-

-

-

-

Leasehold improvements paid by landlord

-

-

286

-

-

-

-

Note payable for insurance premiums

-

-

-

262

0

-

-

Leasehold improvements paid by landlord

-

-

-

0

0

-

-

Unearned restricted stock grants

58

58

381

0

0

-

-

Right-of-use assets obtained in exchange for liabilities

4,453

-

-

-

-

-

-

Warrants issued to placement agent

-

89

-

-

-

-

-

Issuance of stock for services to be rendered

-

-

-

-

-

-

470

Capital lease for equipment purchase

-

-

-

-

-

111

0

Contingent equity consideration for Aquarius Merger

-

-

-

0

753

0

-

Stock consideration for Aquarius merger

-

-

-

0

2,119

0

-

Deemed dividend for convertible preferred stock beneficial conversion feature

-

-

-

4,393

0

-

-

Fair value of placement agent warrants as an issuance cost

-

-

-

0

0

-

-

Stock dividend accrual

-

-

-

0

0

-

-

Stock dividends issued

-

-

7

0

0

-

-

Inducement charges for modification of warrants

-

-

16,741

-

-

-

-

Note payable for insurance premiums

-

399

383

-

-

-

-

Additional paid-in-capital for modification of warrants

-

-

-

0

0

-

-

Equipment acquired under capital lease

-

155

85

31

0

-

-